Log In
Print
BCIQ
Print
Print this Print this
 

MBX-2982, SAR26009

  Manage Alerts
Collapse Summary General Information
Company CymaBay Therapeutics Inc.
DescriptionG protein-coupled receptor 119 (GPR119) agonist
Molecular Target G protein-coupled receptor 119 (GPR119)
Mechanism of ActionG protein-coupled receptor 119 (GPR119) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today